---
title: "12 Health Care Stocks Moving In Wednesday's After-Market Session"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295017431.md"
description: "Several healthcare stocks moved significantly in Wednesday's after-market session following Q2 earnings reports. Gainers included Creative Medical Tech (+31.4%), Caris Life Sciences (+13.98%), and Clover Health (+11.35%). Conversely, losers featured BillionToOne (-24.7%), Emergent BioSolutions (-22.55%), and Mirum Pharmaceuticals (-20.6%). The price fluctuations were directly attributed to the release of quarterly financial results."
datetime: "2026-08-05T21:06:20.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295017431.md)
  - [en](https://longbridge.com/en/news/295017431.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295017431.md)
---

# 12 Health Care Stocks Moving In Wednesday's After-Market Session

### Gainers

-   **Creative Medical Tech** (NASDAQ:CELZ) stock moved upwards by 31.4% to $0.88 during Wednesday's after-market session. The company's market cap stands at $4.2 million.
-   **Caris Life Sciences** (NASDAQ:CAI) stock moved upwards by 13.98% to $18.75. The company's market cap stands at $4.5 billion. As per the news, the Q2 earnings report came out today.
-   **Clover Health Investments** (NASDAQ:CLOV) stock moved upwards by 11.35% to $4.61. The company's market cap stands at $2.2 billion. The company's, Q2 earnings came out today.
-   **Arcutis Biotherapeutics** (NASDAQ:ARQT) stock moved upwards by 10.14% to $29.85. The company's market cap stands at $3.2 billion. As per the press release, Q2 earnings came out today.
-   **Myomo** (AMEX:MYO) shares moved upwards by 9.27% to $1.16. The company's market cap stands at $41.7 million. As per the news, the Q2 earnings report came out today.
-   **Orthofix Medical** (NASDAQ:OFIX) shares increased by 9.11% to $11.37. The market value of their outstanding shares is at $493.1 million. The company's, Q2 earnings came out today.

### Losers

-   **BillionToOne** (NASDAQ:BLLN) shares fell 24.7% to $113.0 during Wednesday's after-market session. The company's market cap stands at $6.5 billion. As per the press release, Q3 earnings came out today.
-   **Emergent BioSolutions** (NYSE:EBS) stock fell 22.55% to $5.84. The company's market cap stands at $392.1 million. As per the press release, Q2 earnings came out today.
-   **Mirum Pharmaceuticals** (NASDAQ:MIRM) stock declined by 20.6% to $84.0. The company's market cap stands at $6.3 billion. As per the news, the Q2 earnings report came out today.
-   **Akebia Therapeutics** (NASDAQ:AKBA) shares decreased by 20.16% to $1.03. The company's market cap stands at $354.1 million. As per the news, the Q2 earnings report came out today.
-   **Biote** (NASDAQ:BTMD) stock decreased by 14.61% to $1.93. The market value of their outstanding shares is at $68.8 million. As per the news, the Q2 earnings report came out today.
-   **Zhengye Biotechnology** (NASDAQ:ZYBT) stock fell 12.72% to $2.06. The market value of their outstanding shares is at $60.6 million. **See Also:** www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

### Related Stocks

- [CELZ.US](https://longbridge.com/en/quote/CELZ.US.md)
- [BLLN.US](https://longbridge.com/en/quote/BLLN.US.md)
- [CAI.US](https://longbridge.com/en/quote/CAI.US.md)
- [CLOV.US](https://longbridge.com/en/quote/CLOV.US.md)
- [MIRM.US](https://longbridge.com/en/quote/MIRM.US.md)
- [EBS.US](https://longbridge.com/en/quote/EBS.US.md)
- [ARQT.US](https://longbridge.com/en/quote/ARQT.US.md)
- [MYO.US](https://longbridge.com/en/quote/MYO.US.md)
- [OFIX.US](https://longbridge.com/en/quote/OFIX.US.md)
- [AKBA.US](https://longbridge.com/en/quote/AKBA.US.md)
- [BTMD.US](https://longbridge.com/en/quote/BTMD.US.md)
- [ZYBT.US](https://longbridge.com/en/quote/ZYBT.US.md)

## Related News & Research

- [Clover Health Investments (NASDAQ:CLOV) Posts Quarterly Earnings Results, Beats Estimates By $0.01 EPS](https://longbridge.com/en/news/295028079.md)
- [Clover Health Q2 revenue rises 56%, beating estimates on memership growth](https://longbridge.com/en/news/295008626.md)
- [Mirum SVP, Global Controller Jolanda Howe sells 1,840 shares for $193,733.6](https://longbridge.com/en/news/295010149.md)
- [Mirum Pharmaceuticals Q2 sales rise, lifts outlook](https://longbridge.com/en/news/295007489.md)
- [Creative Medical gets USPTO notice of allowance for exosome-based Type 1 diabetes immunotherapy patent application](https://longbridge.com/en/news/295116081.md)